Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,031 | 585 | 99.6% |
| Education | $37.72 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,174 | 128 | $0 (2024) |
| PFIZER INC. | $1,216 | 80 | $0 (2022) |
| Lilly USA, LLC | $962.48 | 53 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $962.10 | 58 | $0 (2024) |
| GlaxoSmithKline, LLC. | $861.93 | 53 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $601.61 | 39 | $0 (2023) |
| Amgen Inc. | $559.79 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $452.39 | 19 | $0 (2022) |
| Merck Sharp & Dohme LLC | $305.34 | 20 | $0 (2022) |
| Amarin Pharma Inc. | $246.25 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.56 | 22 | Lilly USA, LLC ($116.17) |
| 2023 | $500.75 | 29 | GlaxoSmithKline, LLC. ($168.76) |
| 2022 | $1,025 | 59 | Lilly USA, LLC ($347.81) |
| 2021 | $796.33 | 56 | Novo Nordisk Inc ($222.01) |
| 2020 | $1,458 | 99 | Novo Nordisk Inc ($358.97) |
| 2019 | $1,712 | 114 | Novo Nordisk Inc ($467.85) |
| 2018 | $2,222 | 113 | Novo Nordisk Inc ($483.76) |
| 2017 | $1,916 | 98 | Novo Nordisk Inc ($340.12) |
All Payment Transactions
590 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Cardio-renal | ||||||
| 10/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Obesity | ||||||
| 09/10/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Neurology | ||||||
| 08/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardio-renal | ||||||
| 08/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Diabetes | ||||||
| 06/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Obesity | ||||||
| 04/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Obesity | ||||||
| 03/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Inflammation | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: Diabetes | ||||||
| 02/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardio-renal | ||||||
| 01/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Oncology | ||||||
| 12/13/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Hematology | ||||||
| 12/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 87 | 438 | $49,880 | $22,359 |
| 2022 | 6 | 253 | 661 | $84,948 | $34,928 |
| 2021 | 17 | 868 | 1,312 | $161,940 | $73,427 |
| 2020 | 14 | 707 | 1,167 | $140,336 | $55,490 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 250 | $42,500 | $18,246 | 42.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 29 | 172 | $6,020 | $3,659 | 60.8% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Office | 2023 | 16 | 16 | $1,360 | $454.20 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 397 | $67,490 | $27,362 | 40.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 24 | 156 | $5,460 | $3,754 | 68.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 20 | $4,590 | $1,805 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 34 | $4,080 | $1,184 | 29.0% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Office | 2022 | 21 | 21 | $1,513 | $604.63 | 40.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 33 | $1,815 | $218.36 | 12.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 193 | 493 | $83,890 | $38,195 | 45.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 50 | 70 | $15,400 | $8,631 | 56.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 124 | $14,880 | $6,299 | 42.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 106 | 111 | $10,395 | $3,603 | 34.7% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 41 | 41 | $3,690 | $2,676 | 72.5% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 60 | 62 | $4,030 | $2,308 | 57.3% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 37 | 37 | $2,290 | $2,233 | 97.5% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 100 | 100 | $5,930 | $2,013 | 33.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 15 | 61 | $2,135 | $1,587 | 74.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 12 | 12 | $1,980 | $1,499 | 75.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 84 | 84 | $3,780 | $1,332 | 35.2% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 13 | 13 | $6,500 | $1,207 | 18.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 19 | $2,280 | $771.78 | 33.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 25 | 41 | $2,255 | $434.03 | 19.2% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 14 | 15 | $1,125 | $322.34 | 28.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $360.00 | $189.82 | 52.7% |
About Dr. Seth Jarrell, M.D
Dr. Seth Jarrell, M.D is a Internal Medicine healthcare provider based in Florence, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2013. The National Provider Identifier (NPI) number assigned to this provider is 1891135208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seth Jarrell, M.D has received a total of $10,069 in payments from pharmaceutical and medical device companies, with $438.56 received in 2024. These payments were reported across 590 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($10,031).
As a Medicare-enrolled provider, Jarrell has provided services to 1,915 Medicare beneficiaries, totaling 3,578 services with total Medicare billing of $186,205. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Florence, AL
- Active Since 06/29/2013
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891135208
Products in Payments
- Ozempic (Drug) $1,086
- FARXIGA (Drug) $710.89
- TRELEGY ELLIPTA (Drug) $621.63
- JARDIANCE (Drug) $599.56
- MOUNJARO (Drug) $498.85
- CHANTIX (Drug) $477.70
- Tresiba (Drug) $322.69
- TRULICITY (Drug) $280.19
- Saxenda (Drug) $265.27
- XARELTO (Drug) $254.88
- Victoza (Drug) $249.19
- Vascepa (Drug) $246.25
- ELIQUIS (Drug) $199.75
- INVOKANA (Drug) $197.51
- LYRICA (Drug) $194.81
- Aimovig (Biological) $184.73
- Trintellix (Drug) $172.76
- Wegovy (Drug) $153.89
- Repatha (Biological) $148.79
- Cologuard Collection Kit (Device) $143.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Florence
Cyrus Kocherla, Md, MD
Internal Medicine — Payments: $113,901
Dr. Subir Paul, M.d, M.D
Internal Medicine — Payments: $75,565
Dr. John Patton, Md, MD
Internal Medicine — Payments: $47,520
Dr. Rishika Motiani, M.d, M.D
Internal Medicine — Payments: $45,711
Davinderbir Pannu, Md, MD
Internal Medicine — Payments: $43,684
Dr. Justin Case, Md, MD
Internal Medicine — Payments: $23,099